Moderna’s mRNA-1083 Vaccine Could Combat COVID and Influenza All in One Shot
Moderna is in Phase 3 of its clinical trial for mRNA-1083, a combined COVID and influenza vaccine. The President of Moderna, Stephen Hoge, announced that
Moderna is in Phase 3 of its clinical trial for mRNA-1083, a combined COVID and influenza vaccine. The President of Moderna, Stephen Hoge, announced that